Therapeutic Clues from an Integrated Omic Assessment of East Asian Triple Negative Breast Cancers.
Journal
Cancer cell
ISSN: 1878-3686
Titre abrégé: Cancer Cell
Pays: United States
ID NLM: 101130617
Informations de publication
Date de publication:
18 03 2019
18 03 2019
Historique:
entrez:
20
3
2019
pubmed:
20
3
2019
medline:
18
12
2019
Statut:
ppublish
Résumé
In this issue of Cancer Cell, Jiang et al. report a genomic and transcriptional analysis of triple negative breast cancers (TNBCs) from an East Asian population. Their study shows minor differences with published studies of European and North American populations and suggests a therapeutic decision tree for treatment of TNBC.
Identifiants
pubmed: 30889376
pii: S1535-6108(19)30107-2
doi: 10.1016/j.ccell.2019.02.012
pmc: PMC6499473
mid: NIHMS1025532
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
341-343Subventions
Organisme : NCI NIH HHS
ID : U01 CA217842
Pays : United States
Organisme : NCI NIH HHS
ID : U2C CA233280
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA209988
Pays : United States
Organisme : NHGRI NIH HHS
ID : U54 HG008100
Pays : United States
Commentaires et corrections
Type : CommentOn
Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.
Références
Cancer. 2015 Jan 1;121(1):8-16
pubmed: 25043972
Cancer Cell. 2019 Mar 18;35(3):428-440.e5
pubmed: 30853353
JAMA Oncol. 2017 Dec 1;3(12):1654-1662
pubmed: 28472234
Breast Cancer Res. 2014 Aug 08;16(4):406
pubmed: 25103565
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
Oncotarget. 2019 Jan 4;10(2):198-208
pubmed: 30719214
Nature. 2012 Apr 18;486(7403):346-52
pubmed: 22522925
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
PLoS One. 2016 Jun 16;11(6):e0157368
pubmed: 27310713
Nature. 2000 Aug 17;406(6797):747-52
pubmed: 10963602